Amgen Inc.: accounts_receivable
| Value | {"amount": 6776000000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2024-03-31) |
| Status | current |
| Entity | Amgen Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:29:19.522005+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b54fa909-244a-48c1-8bfe-68d4060c490d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000318154-24-000020Retrieved: 2026-08-19T07:29:19.522005+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000318154/accounts-receivable/2024-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b54fa909-244a-48c1-8bfe-68d4060c490d
History
- no predecessors — first report